| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b25cf8265f5391a0e721a91c17826e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67db26f5715530deef4738b26c8eb102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6d6b8be69bd00c9c554de92d7f234c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_569a507acb179bb96683ccdce06486f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a567b6ca7cfbe99443ad49729c19c80b |
| publicationDate |
2022-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022257698-A1 |
| titleOfInvention |
Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer |
| abstract |
The present invention relates to the cyclic peptides that are agonists of the angiotensin II type 2 receptor (hereinafter the AT2 receptor) useful in the treatment of different types of solid cancer, in particular brain, colon, lung and ovarian cancer. The invention further relates to pharmaceutical compositions containing them and uses thereof for the treatment of cancer. |
| priorityDate |
2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |